Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1996International PsychogeriatricsOpen Access

Utility of Clinical Trial Batteries in the Measurement of Alzheimer’s and Huntington’s Dementia

View Full Paper
Ask AI
Bookmark
Share

Authors

EMErich MohrMedGenesis Therapeutix (Canada)DWDenise L. WalkerUniversity of ManchesterMSMargaret SampsonLibrary and Archives Canada

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mohr et al. (1996) studied this question.

synapsesocial.com/papers/6a9c4d5ee4895faeb35d243chttps://doi.org/10.1017/s1041610296002761
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Controlled Trial of Tacrine in Alzheimer's Disease1992 · 400 citations
  2. 2Are all subcortical dementias Alike?: Verbal learning and memory in Parkinson's and huntington's disease patients1990 · 211 citations
  3. 3A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group1994 · 1,008 citations
  4. 4DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's Disease1989 · 356 citations
  5. 5Aphasia in dementia of the Alzheimer type1985 · 340 citations